Facts and Stats

People with localized esophageal cancer and advanced melanoma have benefited from improved cancer care.

by Thomas Celona

Researchers hope effective telehealth will increase access to palliative care for more cancer patients.

by Taneia Surles

Blood tests, often called liquid biopsy, could be key to early cancer detection and monitoring response to treatment.

by Cancer Research Catalyst

The AACR hosts a roundtable to ‘get real’ about cancer health disparities.

by Marci A. Landsmann

A higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.

by Kyle Bagenstose

The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.

by Laura Gesualdi-Gilmore

FDA approval allows patients to collect samples for HPV test, lowering a barrier to an important cancer prevention tool.

by Taneia Surles

Facts and Stats

Decades of research and clinical trials led to CAR T-cell therapy becoming a critical blood cancer treatment.

by Thomas Celona

Immune checkpoint inhibitors are effective against non-small cell lung cancer in some patients. Researchers are investigating who benefits from the drugs and when they should be administered for maximum impact.

by Natalie Slivinski

With the FDA’s approval of the first tumor‑infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, researchers seek to expand this type of cellular therapy to other solid tumors.

by Kendall K. Morgan